Affimed Therapeutics AG Raises $20 Million in a Series D Financing Round
10/8/2012 7:38:13 AM
More...
|
Affimed Therapeutics AG Raises E 20 million in a Series C Financing Round
4/29/2010 7:24:52 AM
More...
|
Affimed Therapeutics AG Successfully Completes Preclinical Development of AFM 13
2/8/2010 9:18:28 AM
More...
|
Affimed Therapeutics AG Completes Move Into Drug Development
1/14/2010 11:16:28 AM
More...
|
Affimed Therapeutics AG Receives FDA Orphan Drug Designation for AFM13 against Hodgkin Lymphoma
9/15/2009 1:38:24 PM
More...
|
Affimed Therapeutics AG Joins the Molecular Imaging Technology Initiative
2/9/2009 1:05:25 PM
More...
|
Affimed Therapeutics AG Appoints Chief Business Officer
6/5/2008 1:28:30 PM
More...
|
Affimed Therapeutics AG Increases Series B Financing in Second Closing to S45 M
2/20/2008 6:44:09 AM
More...
|
Affimed Therapeutics AG Closes US $32M Series B Financing
4/4/2007 9:50:19 AM
More...
|
The Day In Review: Gilead Sciences (Foster City, CA) (GILD) Gets Myogen (MYOG) In $2.5 Billion Deal
10/2/2006 5:50:04 PM
More...
|
|